All In Biotech

Drug Trial Radar · NCT02812121

UC-MSC Infusion for HBV-Related Acute-on-Chronic Liver Failure

Umbilical Cord Blood Derived Mesenchymal Stem Cells Infusion for HBV-Related Acute-on-Chronic Liver Failure: A Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Jun 24, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 261 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

261

Planned (sponsor's estimate)

Start

Jun 2016

Primary completion

Jun 2017

Study completion Jun 2018

Sponsor

Lead sponsor
Sun Yat-sen UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 24, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF) is a severe disease with high mortality. Our previous study have demonstrated that peripheral infusion of bone marrow-derived mesenchymal stromal cells (MSCs) weekly for 4 times is safe and improves 24 weeks survival rate of ACLF patients. In this study, we intend to assess the safety and efficacy of umbilical cord blood derived MSCs for HBV-related ACLF patients.

Conditions

  • Liver Failure

Interventions

  • umbilical cord blood mesenchymal stem cellsDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The incidence of adverse reactions after umbilical cord blood derived mesenchymal stem cells (UC-MSC) infusions.Time frame: 52 weeks
  2. The survival time of patients after UC-MSC infusions.Time frame: 52 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.